This inventor holds 16 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Kura Oncology, Inc., Millennium Pharmaceuticals Limited, Kura Oncolofy, Inc.. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Woburn, MA (US) (2017 - 2021)
- North Reading, MA (US) (2019 - 2023)
Company Filing History:
11 out of 34 
4 out of 854 
1 out of 1 Years Active: 2017-2023
Title: Inventor Spotlight: Catherine Rose Scholz
Introduction
Catherine Rose Scholz, an accomplished inventor based in Woburn, MA, has made significant contributions to the field of cancer therapy. With a remarkable portfolio of 16 patents, she has dedicated her career to advancing medical research and developing innovative treatment methods for cancer.
Latest Patents
Among her most notable recent inventions are two patents focusing on methods of treating cancer using farnesyltransferase inhibitors. The first patent discusses a technique for treating conditions like peripheral T-cell lymphoma (PTCL) by assessing gene expression characteristics to determine patient responsiveness to farnesyltransferase inhibitor (FTI) treatment. The second patent further expands on this by incorporating genotyping and expression profiling of certain immunological genes alongside RAS mutation status to guide treatment decisions for cancer patients.
Career Highlights
Catherine has worked with esteemed companies in the biotechnology sector, including Kura Oncology, Inc. and Millennium Pharmaceuticals Limited. Her experience in these organizations has allowed her to refine her expertise in molecular biology and cancer treatment, leading to groundbreaking innovations that have the potential to significantly improve patient outcomes.
Collaborations
Throughout her career, Catherine has collaborated with several prominent researchers, including Antonio Gualberto and Irving H. Fox. These collaborations enhance the scope of her research and facilitate the development of more effective cancer therapies through shared knowledge and expertise.
Conclusion
Catherine Rose Scholz exemplifies the spirit of innovation in the medical field, with her extensive patent portfolio and impactful collaborations. Her work in cancer therapy not only contributes to scientific advancement but also offers hope to patients seeking effective treatment options. As she continues to push the boundaries of research, her inventions will undoubtedly play a vital role in the future of cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile